Cigna Group (CI)
(Delayed Data from NYSE)
$352.65 USD
-0.53 (-0.15%)
Updated Apr 23, 2024 04:00 PM ET
After-Market: $352.69 +0.04 (0.01%) 7:58 PM ET
3-Hold of 5 3
A Value C Growth B Momentum A VGM
Cigna (CI) Price Targets
Average Price Target | Highest Price Target | Lowest Price Target | Upside to Average Price Target |
---|---|---|---|
$384.25 | $432.00 | $348.00 | 8.80% |
Price Target
Based on short-term price targets offered by 20 analysts, the average price target for Cigna comes to $384.25. The forecasts range from a low of $348.00 to a high of $432.00. The average price target represents an increase of 8.8% from the last closing price of $353.18.
Analyst Price Targets (20)
Broker Rating
Cigna currently has an average brokerage recommendation (ABR) of 1.45 on a scale of 1 to 5 (Strong Buy to Strong Sell), calculated based on the actual recommendations (Buy, Hold, Sell etc.) made by 21 brokerage firms. The current ABR compares to an ABR of 1.45 a month ago based on 21 recommendations.
Of the 21 recommendations deriving the current ABR, 15 are Strong Buy and two are Buy. Strong Buy and Buy respectively account for 71.43% and 9.52% of all recommendations. A month ago, Strong Buy made up 71.43%, while Buy represented 9.52%.
Broker Rating Breakdown
Brokerage Recommendations
Today | 1 Week Ago | 1 Month Ago | 2 Months Ago | 3 Months Ago | |
---|---|---|---|---|---|
Strong Buy | 15 | 15 | 15 | 14 | 12 |
Buy | 2 | 2 | 2 | 2 | 1 |
Hold | 4 | 4 | 4 | 4 | 6 |
Sell | 0 | 0 | 0 | 0 | 0 |
Strong Sell | 0 | 0 | 0 | 0 | 0 |
ABR | 1.45 | 1.45 | 1.45 | 1.48 | 1.66 |
1. Not Ident. Many of the brokerage firms who provide Zacks data ask that we keep their identity confidential.
2. In most cases the # of brokers listed above is less than the # of brokerage firms that have a recommendation on the stock. That is because some firms prohibit Zacks from displaying detailed information on their recommendations such as in the upgrade/downgrade table.
Analyst Upgrades/Downgrades
Date | Brokerage Firm | Analyst | Previous | Current |
---|---|---|---|---|
3/8/2024 | Mizuho SecuritiesUSA | Ann K Hynes | Strong Buy | Strong Buy |
3/8/2024 | Truist Securities | David S Macdonald | Strong Buy | Strong Buy |
3/4/2024 | Cantor Fitzgerald & Co | Sarah James | Strong Buy | Strong Buy |
2/1/2024 | Stephens | Scott Fidel | Strong Buy | Strong Buy |
11/3/2023 | SVB Securities | Whit Mayo | Hold | Hold |
8/18/2023 | Edward D. Jones & Company | John Boylan | Not Available | Hold |
8/7/2023 | Raymond James | John W Ransom | Strong Buy | Strong Buy |
1. Not Ident. Many of the brokerage firms who provide Zacks data ask that we keep their identity confidential.
2. In most cases the # of brokers listed above is less than the # of brokerage firms that have a recommendation on the stock. That is because some firms prohibit Zacks from displaying detailed information on their recommendations such as in the upgrade/downgrade table.
Average Brokerage Rating
Current ABR | 1.45 |
ABR (Last week) | 1.45 |
# of Recs in ABR | 21 |
Average Target Price | $384.25 |
LT Growth Rate | 11.50% |
Industry | Medical - HMOs |
Industry Rank by ABR | 200 of 252 |
Current Quarter EPS Est: | 6.17 |